Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature Chemical Biology

• Publication date

  2017-08-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nchembio.2458PMID 28805801PMCID PMC5693369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mediator cyclin‐dependent kinases upregulate transcription of inflammatory genes in cooperation with NF‐κB and C/EBPβ on stimulation of Toll‐like receptor 9

  2017cited by this paper
• Simultaneous Pathway Activity Inference and Gene Expression Analysis Using RNA Sequencing.

  2016cited by this paper
• Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases

  2016cited by this paper
• Janus kinase inhibitors for rheumatoid arthritis.

  2016cited by this paper
• Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo.

  2016cited by this paper
• Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics.

  2016cited by this paper
• Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19

  2016cited by this paper
• Apremilast for the treatment of psoriatic arthritis

  2015cited by this paper
• Mediator Kinase Inhibition Further Activates Super-Enhancer Associated Genes in AML

  2015cited by this paper
• Super-enhancers: Asset management in immune cell genomes.

  2015cited by this paper
• The early synthesis of p35 and activation of CDK5 in LPS-stimulated macrophages suppresses interleukin-10 production

  2015cited by this paper
• The Mediator complex: a central integrator of transcription

  2015cited by this paper
• LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures

  2014cited by this paper
• Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

  2014cited by this paper
• Polarization of the Innate Immune Response by Prostaglandin E2: A Puzzle of Receptors and Signals

  2014cited by this paper
• Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells

  2014cited by this paper
• Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling

  2014cited by this paper
• Microtubule acetylation amplifies p38 kinase signaling and anti-inflammatory IL-10 production

  2014cited by this paper
• A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate.

  2014cited by this paper
• Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.

  2014cited by this paper
• Transcriptional enhancers: from properties to genome-wide predictions

  2014cited by this paper
• Expression of CD163, interleukin-10, and interferon-gamma in oral squamous cell carcinoma: mutual relationships and prognostic implications.

  2014cited by this paper
• Cyclin C is a haploinsufficient tumour suppressor

  2014cited by this paper
• Scaffold mining of kinase hinge binders in crystal structure database

  2013cited by this paper
• Why interleukin-10 supplementation does not work in Crohn's disease patients.

  2013cited by this paper
• CDK8 Kinase Phosphorylates Transcription Factor STAT1 to Selectively Regulate the Interferon Response

  2013cited by this paper
• CSF-1R inhibition alters macrophage polarization and blocks glioma progression

  2013cited by this paper
• Cdks, cyclins and CKIs: roles beyond cell cycle regulation

  2013cited by this paper
• Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities

  2012cited by this paper
• Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages

  2012cited by this paper
• A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals.

  2012cited by this paper
• Robust rank aggregation for gene list integration and meta-analysis

  2012cited by this paper
• DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells.

  2012cited by this paper
• Scalable synthesis of cortistatin A and related structures.

  2011cited by this paper
• IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence

  2010cited by this paper
• Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action.

  2010cited by this paper
• The regulation of IL-10 production by immune cells

  2010cited by this paper
• CDK8 is a positive regulator of transcriptional elongation within the serum response network

  2010cited by this paper
• edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

  2009cited by this paper
• CC-10004 but not thalidomide or lenalidomide inhibits lamina propria mononuclear cell TNF-α and MMP-3 production in patients with inflammatory bowel disease.

  2009cited by this paper
• Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1

  2008cited by this paper
• Calcineurin-mediated dephosphorylation of c-Jun Ser-243 is required for c-Jun protein stability and cell transformation

  2008cited by this paper
• A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease.

  2006cited by this paper
• Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3

  2005cited by this paper
• Identification of a Macrophage-Specific Chromatin Signature in the IL-10 Locus1

  2005cited by this paper
• Theoretical and practical advances in genome halving

  2004cited by this paper
• Interleukin-10 Therapy—Review of a New Approach

  2003cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.

  2000cited by this paper
• Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity.

  1992cited by this paper

• Phenotype-Led Identification of IL-10 Upregulators in Human CD4+ T-cells and Elucidation of Their Pharmacology as Highly Selective CDK8/CDK19 Inhibitors.

  2025cites this paper
• Discovery and chemical biology of CDK8 inhibitors reveals insights for kinase inhibitor development

  2025cites this paper
• Lyn expression in macrophages promotes TLR activation and restricts proliferation in an isoform-independent manner

  2025cites this paper
• CDK8 is a critical effector of cell fate dysregulation in SF3B1-mutant MDS

  2025cites this paper
• Discovery of lipid metabolism-related diagnostic biomarkers and construction of diagnostic model in steroid-induced osteonecrosis of femoral head

  2025cites this paper
• Total, not isoform-specific, Lyn expression by macrophages promotes TLR activation and restricts proliferation

  2025cites this paper
• Mediator Kinase Inhibitor Selectivity and Activity in Colorectal Cancer

  2025cites this paper
• Submicron-Sampling of Living Cells by Macrophages

  2025cites this paper
• A comprehensive review of small molecules, targets, and pathways in ulcerative colitis treatment.

  2025cites this paper
• Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome

  2025cites this paper
• Clinical Diagnostic Value of miR-193a-5p in Neonatal Acute Respiratory Distress Syndrome and Analysis of Its Effect on Human Lung Epithelial Cells

  2025cites this paper
• CDK8 mediated inflammatory microenvironment aggravates osteoarthritis progression

  2025influential citation
• The discovery of a novel pyrrolo[2,3-b]pyridine as a selective CDK8 inhibitor offers a new approach against psoriasis.

  2024cites this paper
• Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer's disease model.

  2024cites this paper
• CDK8/19 inhibitor enhances arginase-1 expression in macrophages via STAT6 and p38 MAPK activation.

  2024cites this paper
• Bromo-substituted indirubins for inhibition of protein kinase-mediated signalling involved in inflammatory mediator release in human monocytes.

  2024cites this paper
• Unveiling the impact of CDK8 on tumor progression: mechanisms and therapeutic strategies

  2024cites this paper
• Design, synthesis, and biological evaluation of indolin-2-one derivatives as novel cyclin-dependent protein kinase 8 (CDK8) inhibitors.

  2023cites this paper
• Microglia Depletion Reduces Human Neuronal APOE4-Driven Pathologies in a Chimeric Alzheimer’s Disease Model

  2023cites this paper
• Small molecule inhibitors of transcriptional cyclin-dependent kinases impose HIV-1 latency, presenting “block and lock” treatment strategies

  2023influential citation
• The gut protist Tritrichomonas arnold restrains virus-mediated loss of oral tolerance by modulating dietary antigen-presenting dendritic cells.

  2023cites this paper
• Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome

  2023cites this paper
• CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells

  2023cites this paper
• A novel CDK8 inhibitor with poly-substituted pyridine core: Discovery and anti-inflammatory activity evaluation in vivo.

  2023cites this paper
• The E3 ligase TRIM31 regulates hematopoietic stem cell homeostasis and MLL-AF9 leukemia

  2023cites this paper
• CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium

  2022cites this paper
• The Mediator kinase module: an interface between cell signaling and transcription.

  2022cites this paper
• Multi-omics evaluation of SARS-CoV-2 infected mouse lungs reveals dynamics of host responses

  2022cites this paper
• Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts.

  2022cites this paper
• Discovery and Anti-Inflammatory Activity Evaluation of a Novel CDK8 Inhibitor through Upregulation of IL-10 for the Treatment of Inflammatory Bowel Disease In Vivo.

  2022cites this paper
• Cyclin-dependent kinase 8 is an independent prognosticator in uterine leiomyosarcoma.

  2022cites this paper
• Drug Repositioning Identifies Six Drug Candidates for Systemic Autoimmune Diseases by Integrative Analyses of Transcriptomes from Scleroderma, Systemic Lupus Erythematosus, and Sjogren's Syndrome

  2022cites this paper
• The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway

  2021influential citation
• Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies

  2021cites this paper
• Nuisance compounds in cellular assays.

  2021cites this paper
• Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment

  2021cites this paper
• Effect of Xingbi Gel Nasal Drops on Fyn-STAT5 Pathway in Nasal Mucosa Fibroblasts of Guinea Pigs with Allergic Rhinitis

  2021cites this paper
• Hit Triage and Validation in Phenotypic Screening: Considerations and Strategies.

  2020cites this paper
• Angel or Devil ? - CDK8 as the new drug target.

  2020cites this paper
• Kinase inhibition in autoimmunity and inflammation

  2020cites this paper
• Transcriptional cyclin-dependent kinases as the mediators of inflammation-a review.

  2020cites this paper
• UTX/KDM6A suppresses AP-1 and a gliogenesis program during neural differentiation of human pluripotent stem cells

  2020cites this paper
• Immunomodulation by anticancer cell cycle inhibitors

  2020cites this paper
• Binding patterns and structure-activity relationship of CDK8 inhibitors.

  2020cites this paper
• Small-molecule targeting of brachyury transcription factor addiction in chordoma

  2019cites this paper
• DCA promotes a novel tolerogenic program in CD 4 + T cells by inhibiting CDK 8

  2019influential citation
• Discovery and Development of Cyclin-Dependent Kinase 8 Inhibitors.

  2019cites this paper
• CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.

  2019cites this paper
• Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 Functions.

  2019cites this paper
• The CDK8 inhibitor DCA promotes a tolerogenic chemical immunophenotype in CD4+ T cells via a novel CDK8-GATA3-FOXP3 pathway

  2019cites this paper
• Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019).

  2019cites this paper
• Inhibition of Cdk8/Cdk19 Activity Promotes Treg Cell Differentiation and Suppresses Autoimmune Diseases

  2019influential citation
• Transcriptional responses to IFN-γ require Mediator kinase-dependent pause release and mechanistically distinct functions of CDK8 and CDK19

  2019influential citation
• Local microRNAs in peritoneal dialysis-related peritonitis

  2019cites this paper
• Role of transcription-regulating kinase CDK8 in colon cancer metastasis

  2019cites this paper
• Kinase inhibitors: the road ahead

  2018cites this paper
• Regulatory functions of the Mediator kinases CDK8 and CDK19

  2018cites this paper
• Therapeutic targeting of transcriptional cyclin-dependent kinases

  2018influential citation
• CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases.

  2018cites this paper
• Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy?

  2018cites this paper
• The Role Of Cdk8 In Metastatic Growth Of Colon Cancer

  2018cites this paper
• CDK19 is a Regulator of Triple-Negative Breast Cancer Growth

  2018cites this paper
• CDK 8 as a therapeutic target for cancers and recent developments in discovery of CDK 8 inhibitors

  2018cites this paper